ReShape Lifesciences (RSLS) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

ReShape Lifesciences Revenue Highlights

Latest Revenue (Y)

$8.68M

Latest Revenue (Q)

$2.29M

Main Segment (Y)

Product

Main Geography (Y)

United States

ReShape Lifesciences Revenue by Period

ReShape Lifesciences Revenue by Year

Date	Revenue	Change
2023-12-31	$8.68M	-22.79%
2022-12-31	$11.24M	-17.35%
2021-12-31	$13.60M	20.36%
2020-12-31	$11.30M	-25.12%
2019-12-31	$15.09M	2387.02%
2018-12-31	$606.71K	-52.86%
2017-12-31	$1.29M	63.62%
2016-12-31	$786.66K	169.40%
2015-12-31	$292.00K	100.00%
2014-12-31	-	100.00%
2013-12-31	-	-100.00%
2012-12-31	$312.00K	100.00%
2011-12-31	-	100.00%
2010-12-31	-	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	100.00%
2006-12-31	-	100.00%
2005-12-31	-	100.00%
2004-12-31	-	100.00%
2003-12-31	-	-

ReShape Lifesciences generated $8.68M in revenue during NA 2023, up -22.79% compared to the previous quarter, and up 1430.34% compared to the same period a year ago.

ReShape Lifesciences Revenue by Quarter

Date	Revenue	Change
2024-09-30	$2.29M	16.64%
2024-06-30	$1.97M	1.08%
2024-03-31	$1.94M	-1.92%
2023-12-31	$1.98M	-8.03%
2023-09-30	$2.15M	-4.39%
2023-06-30	$2.25M	-1.44%
2023-03-31	$2.29M	-26.46%
2022-12-31	$3.11M	11.15%
2022-09-30	$2.80M	-3.25%
2022-06-30	$2.89M	18.52%
2022-03-31	$2.44M	-22.34%
2021-12-31	$3.14M	-15.26%
2021-09-30	$3.71M	5.07%
2021-06-30	$3.53M	9.56%
2021-03-31	$3.22M	0.47%
2020-12-31	$3.21M	-10.99%
2020-09-30	$3.60M	111.63%
2020-06-30	$1.70M	-38.97%
2020-03-31	$2.79M	-31.14%
2019-12-31	$4.05M	15.22%
2019-09-30	$3.52M	-21.01%
2019-06-30	$4.45M	44.76%
2019-03-31	$3.07M	-328.23%
2018-12-31	$-1.35M	-484.57%
2018-09-30	$350.24K	-46.40%
2018-06-30	$653.37K	-31.22%
2018-03-31	$950.00K	19.64%
2017-12-31	$794.03K	120.55%
2017-09-30	$360.02K	286.87%
2017-06-30	$93.06K	132.42%
2017-03-31	$40.04K	-71.78%
2016-12-31	$141.90K	-52.18%
2016-09-30	$296.76K	7.52%
2016-06-30	$276.00K	283.33%
2016-03-31	$72.00K	-51.68%
2015-12-31	$149.00K	132.81%
2015-09-30	$64.00K	-18.99%
2015-06-30	$79.00K	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	-100.00%
2012-06-30	$188.40K	53.06%
2012-03-31	$123.09K	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

ReShape Lifesciences generated $2.29M in revenue during Q3 2024, up 16.64% compared to the previous quarter, and up 101.69% compared to the same period a year ago.

ReShape Lifesciences Revenue Breakdown

ReShape Lifesciences Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 18
Product	$606.71K

ReShape Lifesciences's latest annual revenue breakdown by segment (product or service), as of Dec 18: Product (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 18	Jun 18	Mar 18
Product	$335.95K	$633.55K	$941.43K
Product And Service Other	$14.29K	$19.82K	$8.57K

ReShape Lifesciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 18: Product (95.92%), and Product And Service Other (4.08%).

ReShape Lifesciences Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21
Australia	$526.00K	$688.00K	$1.04M
United States	$7.13M	$9.23M	$10.30M
Europe	$956.00K	$1.25M	$2.13M
Rest of world	$62.00K	$70.00K	$137.00K

ReShape Lifesciences's latest annual revenue breakdown by geography, as of Dec 23: United States (82.21%), Europe (11.02%), Australia (6.06%), and Rest of world (0.71%).

Quarterly Revenue by Country

Country	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
AUSTRALIA	$103.00K	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$1.66M	-	-	-	-	-	-	-	-	-	-	-	-
Non-US	$1.00K	-	-	-	-	-	-	-	-	-	-	-	-
Europe	$198.00K	$198.00K	$201.00K	$258.00K	$193.00K	$304.00K	$243.00K	$206.00K	$389.00K	$414.00K	$505.00K	$653.00K	$590.00K
Australia	-	$102.00K	$107.00K	$139.00K	$123.00K	$157.00K	$155.00K	$164.00K	$188.00K	$181.00K	$190.00K	-	-
Rest of world	-	$26.00K	$14.00K	$26.00K	$9.00K	$13.00K	$47.00K	$16.00K	$7.00K	$1.00K	$47.00K	-	-
United States	-	$1.62M	$1.66M	$1.73M	$1.93M	$1.81M	$2.67M	$2.41M	$2.31M	$1.84M	$2.40M	-	-
U	-	-	-	-	-	-	-	-	-	-	-	$2.75M	$2.63M
Non Us	-	-	-	-	-	-	-	-	-	-	-	$32.00K	$29.00K

ReShape Lifesciences's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (84.63%), Europe (10.08%), AUSTRALIA (5.24%), and Non-US (0.05%).

ReShape Lifesciences Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
HSCS	Heart Test Laboratories	$18.60M	-
NUWE	Nuwellis	$8.86M	$2.37M
RSLS	ReShape Lifesciences	$8.68M	$2.29M
NURO	NeuroMetrix	$5.90M	$587.31K
OPGN	OpGen	$3.42M	-
INVO	INVO Bioscience	$3.02M	$1.58M
TNON	Tenon Medical	$2.93M	$887.00K
SINT	Sintx	$2.63M	$799.00K
TIVC	Tivic Health Systems	$1.18M	$126.00K
HSDT	Helius Medical	$644.00K	$51.00K
IINN	Inspira Technologies Oxy B.H.N.	-	-
BBLG	Bone Biologics	-	-

RSLS Revenue FAQ

What is ReShape Lifesciences’s yearly revenue?

ReShape Lifesciences's yearly revenue for 2023 was $8.68M, representing a decrease of -22.79% compared to 2022. The company's yearly revenue for 2022 was $11.24M, representing a decrease of -17.35% compared to 2021. RSLS's yearly revenue for 2021 was $13.6M, representing an increase of 20.36% compared to 2020.

What is ReShape Lifesciences’s quarterly revenue?

ReShape Lifesciences's quarterly revenue for Q3 2024 was $2.29M, a 16.64% increase from the previous quarter (Q2 2024), and a 6.36% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.96M, a 1.08% increase from the previous quarter (Q1 2024), and a -12.82% decrease year-over-year (Q2 2023). RSLS's quarterly revenue for Q1 2024 was $1.94M, a -1.92% decrease from the previous quarter (Q4 2023), and a -15.00% decrease year-over-year (Q1 2023).

What is ReShape Lifesciences’s revenue growth rate?

ReShape Lifesciences's revenue growth rate for the last 3 years (2021-2023) was -36.19%, and for the last 5 years (2019-2023) was -42.49%.

What are ReShape Lifesciences’s revenue streams?

ReShape Lifesciences's revenue streams in c 18 are Product

What is ReShape Lifesciences’s main source of revenue?

For the fiscal year ending Dec 18, the largest source of revenue of ReShape Lifesciences was Product. This segment made a revenue of $606.71K, representing 100.00% of the company's total revenue.